Navigated Focused Ultrasound
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Navigated Focused Ultrasound, covering 2026-02-04 to 2026-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency [Phase 1]